NCT00987376View on ClinicalTrials.gov

Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Prostate Cancer
Interventions
DEVICE

Diagnostic Imaging: C11 choline PET; C11 acetate PET; and MRI Spectroscopy

C11 Choline, C11 Acetate PET and MRI

Trial Locations (1)

55905

Mayo Clinic Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER